The 5th Annual
Maastricht Institute of Entrepreneurship
at Missouri Valley College Campus
April 11-13, 2011
Founder of Xilloc Medical · Maastricht, the Netherlands
Maikel Beerens developed a methodology during his medical engineering education to design, manufacture and market Patient Specific Implants for the replacement of parts of the human skeleton. Graduated with highest distinction and congratulations of the exam commission and even honoured to receive the technology awards for his thesis in 2006 (Eindhoven, NL). For the case study, serving as a guide through his thesis, Beerens used the Additive Manufacturing Technology (3D printing) for the first time worldwide as the production method of a titanium patient specific implant. This implant was implanted successfully into the patient and positioned the Maastricht University Medical Centre on the map as one of the pioneering groups in this field.
After his thesis he continued working on this topic during his 4 years of professional career within two EC funded 6th Framework Programme projects Custom-Fit and Custom-IMD, developing new biomaterials and additive manufacturing technologies for Patient Specific Implants. During the first 2 years of this period he spent studying Biomedical Engineering Master in part time at the Katholieke Universiteit Leuven,certificate based.
Beerens recently founded Xilloc Medical, he is leading the starting-up of the company, as a young entrepreneur. He gained entrepreneurial experience trough the new venture creation course at the Maastricht centre for entrepreneurship, Maastricht University and trough his start-up. The company is headed to revolutionize the implant industry with the fast and reliable production of patient specific implants to close bone defects of the human skull. Xilloc Medical will bridge the gap between surgeons and their patient specific solution by the use of an innovative system and an experienced team with medical and technical specialists. Prominent players in the field of cranio-maxillofacial reconstruction have already claimed having patient specific implants right at their fingertips a revolution.